CRY1 and chronic kidney disease: Although the exact underlying mechanism of the regulation of the CKD metabolic pathway remains largely unknown, we believe that our findings improve our understanding of the specific mechanism by which the miR-181a-targeted CRY1 has an unfavorable effect on RTE cells in CKD via the TLR/NF-κB pathway.